For Immediate Release: May 25, 2023 Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the … [+5706 chars]Read More
FDA Approves First Oral Antiviral for Treatment of COVID19 in Adults FDAgov
